Immunotech 2015 Q4 Results – Revenue Up 4.9% To $84 Million

Immunotec Inc., a direct-to-consumer company and a leader in the nutritional industry (the “Company” or “Immunotec”), today announced its fourth quarter and year- end consolidated financial results for Fiscal 2015. All amounts in this press release are denominated in Canadian dollars unless otherwise indicated.
“We ended fiscal 2015 with the strongest quarter in Company history both in terms of revenues, Adjusted EBITDA and net profit. This year was marked by solid progress in the U.S. market, as we continue to expand our capabilities in the United States,” said Charles L. Orr, Chief Executive Officer of Immunotec.”
“Revenues for the fourth quarter place the Company on the trajectory to reach $100M in annual revenues. Scale is critical to our business model, and based on a recent industry survey we ranked 97th worldwide among direct selling


Leave a Reply

Your email address will not be published. Required fields are marked *